Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study-Reference-Cited by-同舟云学术

Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study

Published:2023-10 Issue:10 Volume:24 Page:1119-1133
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

van de Donk Niels W C J,Minnema Monique C,van der Holt Bronno,Schjesvold Fredrik,Wu Ka Lung,Broijl Annemiek,Roeloffzen Wilfried W H,Gadisseur Alain,Pietrantuono Giuseppe,Pour Ludek,van der Velden Vincent H J,Lund Thomas,Offidani Massimo,Grasso Mariella,Giaccone Luisa,Razawy Wida,Tacchetti Paola,Mancuso Katia,Silkjaer Trine,Caers Jo,Zweegman Sonja,Hájek Roman,Benjamin Reuben,Vangsted Annette Juul,Boccadoro Mario,Gay Francesca,Sonneveld Pieter,Musto Pellegrino

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands: a population-based study, 1989–2018;Brink;Blood Cancer J,2021

2. Trends in survival of patients with primary plasma cell leukemia: a population-based analysis;Gonsalves;Blood,2014

3. Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy;Nandakumar;Mayo Clin Proc,2021

4. How I treat plasma cell leukemia;van de Donk;Blood,2012

5. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group;Fernández de Larrea;Leukemia,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia;Cancer Medicine;2024-09

2. Biomarker-directed therapy in multiple myeloma;Current Opinion in Oncology;2024-08-23

3. Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study;Annals of Hematology;2024-07-29

4. Risk‐adapted treatment in multiple myeloma: Does more make it merrier?;British Journal of Haematology;2024-07-27

5. Current Status on Management of Primary Plasma Cell Leukemia;Current Oncology Reports;2024-07-02